A similar observation has been made in acute promyelocytic leukemia (APL), a subset of AML in which tumor-derived PGD2 and NKp30-BH76 engagement activates ILC2s to secrete IL-13 that stimulates myeloid-derived suppressor cells (MDSC) [34]. Here, IL13 is linked to acute myeloid leukemia.